PCI instruments can be divided into two categories: interventional therapy instruments and coronary pathway assistive instruments. Interventional treatment instruments mainly include stents and balloon catheters, which include vascular imaging auxiliary instruments (such as vascular imaging guide wires, imaging catheters, puncture needles, catheter sheath sets, ring handle injectors, arterial compression tourniquets, pressure extension tubes, and three-way cocks) and treatment auxiliary instruments (such as balloon dilation pressure pumps, guidance catheters, microwires, etc.) Y-shaped connectors and microcatheters.
The global Coronary Pathway Products market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐oronary Pathway Products Industry Forecast鈥� looks at past sales and reviews total world Coronary Pathway Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Coronary Pathway Products sales for 2023 through 2029. With Coronary Pathway Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronary Pathway Products industry.
This Insight Report provides a comprehensive analysis of the global Coronary Pathway Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Coronary Pathway Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Coronary Pathway Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronary Pathway Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronary Pathway Products.
United States market for Coronary Pathway Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Coronary Pathway Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Coronary Pathway Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Coronary Pathway Products players cover Medtronic, Terumo Corporation, Boston Scientific, Cordis, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Pathway Products market by product type, application, key players and key regions and countries.
Segmentation by Type:
Micro Guide Wire
Guiding Catheter
Microcatheter
Balloon Dilation Pressure Pump
Contrast Catheter
Catheter Sheath Set
Contrast Guide Wire
Arterial Compression Tourniquet
Y-Shaped Connector
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Micro Guide Wire
Guiding Catheter
Microcatheter
Balloon Dilation Pressure Pump
Contrast Catheter
Catheter Sheath Set
Contrast Guide Wire
Arterial Compression Tourniquet
Y-Shaped Connector
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Terumo Corporation
Boston Scientific
Cordis
Abbott
Merit Medical
Curatia Medical
ASAHI INTECC
MicroPort Scientific Corporation
Lepu Medical Technology
Shanghai INT听Medical Instruments
BrosMed Medical
OrbusNeich Medical Company
Shunmei Medical
Suzhou Innomed Medical Device
APT Medical
Zhejiang Barty Medical Technology
Shenzhen MicroApproach Medical Technology
Beijing Demax Medical Technology
Xiamen New Concept Medical Technology
Jiangsu ChangMei Medtech
Jiangxi Hongda Medical Equipment Group
Changzhou JIUHONG Medical Instrument
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coronary Pathway Products Market Size 2019-2030
2.1.2 Coronary Pathway Products Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Coronary Pathway Products by Country/Region, 2019, 2023 & 2030
2.2 Coronary Pathway Products Segment by Type
2.2.1 Micro Guide Wire
2.2.2 Guiding Catheter
2.2.3 Microcatheter
2.2.4 Balloon Dilation Pressure Pump
2.2.5 Contrast Catheter
2.2.6 Catheter Sheath Set
2.2.7 Contrast Guide Wire
2.2.8 Arterial Compression Tourniquet
2.2.9 Y-Shaped Connector
2.3 Coronary Pathway Products Market Size by Type
2.3.1 Coronary Pathway Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Coronary Pathway Products Market Size Market Share by Type (2019-2024)
2.4 Coronary Pathway Products Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Coronary Pathway Products Market Size by Application
2.5.1 Coronary Pathway Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Coronary Pathway Products Market Size Market Share by Application (2019-2024)
3 Coronary Pathway Products Market Size by Player
3.1 Coronary Pathway Products Market Size Market Share by Player
3.1.1 Global Coronary Pathway Products Revenue by Player (2019-2024)
3.1.2 Global Coronary Pathway Products Revenue Market Share by Player (2019-2024)
3.2 Global Coronary Pathway Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Coronary Pathway Products by Region
4.1 Coronary Pathway Products Market Size by Region (2019-2024)
4.2 Global Coronary Pathway Products Annual Revenue by Country/Region (2019-2024)
4.3 Americas Coronary Pathway Products Market Size Growth (2019-2024)
4.4 APAC Coronary Pathway Products Market Size Growth (2019-2024)
4.5 Europe Coronary Pathway Products Market Size Growth (2019-2024)
4.6 Middle East & Africa Coronary Pathway Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas Coronary Pathway Products Market Size by Country (2019-2024)
5.2 Americas Coronary Pathway Products Market Size by Type (2019-2024)
5.3 Americas Coronary Pathway Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coronary Pathway Products Market Size by Region (2019-2024)
6.2 APAC Coronary Pathway Products Market Size by Type (2019-2024)
6.3 APAC Coronary Pathway Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Coronary Pathway Products Market Size by Country (2019-2024)
7.2 Europe Coronary Pathway Products Market Size by Type (2019-2024)
7.3 Europe Coronary Pathway Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coronary Pathway Products by Region (2019-2024)
8.2 Middle East & Africa Coronary Pathway Products Market Size by Type (2019-2024)
8.3 Middle East & Africa Coronary Pathway Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Coronary Pathway Products Market Forecast
10.1 Global Coronary Pathway Products Forecast by Region (2025-2030)
10.1.1 Global Coronary Pathway Products Forecast by Region (2025-2030)
10.1.2 Americas Coronary Pathway Products Forecast
10.1.3 APAC Coronary Pathway Products Forecast
10.1.4 Europe Coronary Pathway Products Forecast
10.1.5 Middle East & Africa Coronary Pathway Products Forecast
10.2 Americas Coronary Pathway Products Forecast by Country (2025-2030)
10.2.1 United States Market Coronary Pathway Products Forecast
10.2.2 Canada Market Coronary Pathway Products Forecast
10.2.3 Mexico Market Coronary Pathway Products Forecast
10.2.4 Brazil Market Coronary Pathway Products Forecast
10.3 APAC Coronary Pathway Products Forecast by Region (2025-2030)
10.3.1 China Coronary Pathway Products Market Forecast
10.3.2 Japan Market Coronary Pathway Products Forecast
10.3.3 Korea Market Coronary Pathway Products Forecast
10.3.4 Southeast Asia Market Coronary Pathway Products Forecast
10.3.5 India Market Coronary Pathway Products Forecast
10.3.6 Australia Market Coronary Pathway Products Forecast
10.4 Europe Coronary Pathway Products Forecast by Country (2025-2030)
10.4.1 Germany Market Coronary Pathway Products Forecast
10.4.2 France Market Coronary Pathway Products Forecast
10.4.3 UK Market Coronary Pathway Products Forecast
10.4.4 Italy Market Coronary Pathway Products Forecast
10.4.5 Russia Market Coronary Pathway Products Forecast
10.5 Middle East & Africa Coronary Pathway Products Forecast by Region (2025-2030)
10.5.1 Egypt Market Coronary Pathway Products Forecast
10.5.2 South Africa Market Coronary Pathway Products Forecast
10.5.3 Israel Market Coronary Pathway Products Forecast
10.5.4 Turkey Market Coronary Pathway Products Forecast
10.6 Global Coronary Pathway Products Forecast by Type (2025-2030)
10.7 Global Coronary Pathway Products Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Coronary Pathway Products Forecast
11 Key Players Analysis
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Coronary Pathway Products Product Offered
11.1.3 Medtronic Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Terumo Corporation
11.2.1 Terumo Corporation Company Information
11.2.2 Terumo Corporation Coronary Pathway Products Product Offered
11.2.3 Terumo Corporation Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Terumo Corporation Main Business Overview
11.2.5 Terumo Corporation Latest Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Company Information
11.3.2 Boston Scientific Coronary Pathway Products Product Offered
11.3.3 Boston Scientific Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boston Scientific Main Business Overview
11.3.5 Boston Scientific Latest Developments
11.4 Cordis
11.4.1 Cordis Company Information
11.4.2 Cordis Coronary Pathway Products Product Offered
11.4.3 Cordis Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cordis Main Business Overview
11.4.5 Cordis Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Coronary Pathway Products Product Offered
11.5.3 Abbott Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Merit Medical
11.6.1 Merit Medical Company Information
11.6.2 Merit Medical Coronary Pathway Products Product Offered
11.6.3 Merit Medical Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merit Medical Main Business Overview
11.6.5 Merit Medical Latest Developments
11.7 Curatia Medical
11.7.1 Curatia Medical Company Information
11.7.2 Curatia Medical Coronary Pathway Products Product Offered
11.7.3 Curatia Medical Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Curatia Medical Main Business Overview
11.7.5 Curatia Medical Latest Developments
11.8 ASAHI INTECC
11.8.1 ASAHI INTECC Company Information
11.8.2 ASAHI INTECC Coronary Pathway Products Product Offered
11.8.3 ASAHI INTECC Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ASAHI INTECC Main Business Overview
11.8.5 ASAHI INTECC Latest Developments
11.9 MicroPort Scientific Corporation
11.9.1 MicroPort Scientific Corporation Company Information
11.9.2 MicroPort Scientific Corporation Coronary Pathway Products Product Offered
11.9.3 MicroPort Scientific Corporation Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MicroPort Scientific Corporation Main Business Overview
11.9.5 MicroPort Scientific Corporation Latest Developments
11.10 Lepu Medical Technology
11.10.1 Lepu Medical Technology Company Information
11.10.2 Lepu Medical Technology Coronary Pathway Products Product Offered
11.10.3 Lepu Medical Technology Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lepu Medical Technology Main Business Overview
11.10.5 Lepu Medical Technology Latest Developments
11.11 Shanghai INT听Medical Instruments
11.11.1 Shanghai INT听Medical Instruments Company Information
11.11.2 Shanghai INT听Medical Instruments Coronary Pathway Products Product Offered
11.11.3 Shanghai INT听Medical Instruments Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Shanghai INT听Medical Instruments Main Business Overview
11.11.5 Shanghai INT听Medical Instruments Latest Developments
11.12 BrosMed Medical
11.12.1 BrosMed Medical Company Information
11.12.2 BrosMed Medical Coronary Pathway Products Product Offered
11.12.3 BrosMed Medical Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BrosMed Medical Main Business Overview
11.12.5 BrosMed Medical Latest Developments
11.13 OrbusNeich Medical Company
11.13.1 OrbusNeich Medical Company Company Information
11.13.2 OrbusNeich Medical Company Coronary Pathway Products Product Offered
11.13.3 OrbusNeich Medical Company Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OrbusNeich Medical Company Main Business Overview
11.13.5 OrbusNeich Medical Company Latest Developments
11.14 Shunmei Medical
11.14.1 Shunmei Medical Company Information
11.14.2 Shunmei Medical Coronary Pathway Products Product Offered
11.14.3 Shunmei Medical Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Shunmei Medical Main Business Overview
11.14.5 Shunmei Medical Latest Developments
11.15 Suzhou Innomed Medical Device
11.15.1 Suzhou Innomed Medical Device Company Information
11.15.2 Suzhou Innomed Medical Device Coronary Pathway Products Product Offered
11.15.3 Suzhou Innomed Medical Device Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Suzhou Innomed Medical Device Main Business Overview
11.15.5 Suzhou Innomed Medical Device Latest Developments
11.16 APT Medical
11.16.1 APT Medical Company Information
11.16.2 APT Medical Coronary Pathway Products Product Offered
11.16.3 APT Medical Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 APT Medical Main Business Overview
11.16.5 APT Medical Latest Developments
11.17 Zhejiang Barty Medical Technology
11.17.1 Zhejiang Barty Medical Technology Company Information
11.17.2 Zhejiang Barty Medical Technology Coronary Pathway Products Product Offered
11.17.3 Zhejiang Barty Medical Technology Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Zhejiang Barty Medical Technology Main Business Overview
11.17.5 Zhejiang Barty Medical Technology Latest Developments
11.18 Shenzhen MicroApproach Medical Technology
11.18.1 Shenzhen MicroApproach Medical Technology Company Information
11.18.2 Shenzhen MicroApproach Medical Technology Coronary Pathway Products Product Offered
11.18.3 Shenzhen MicroApproach Medical Technology Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Shenzhen MicroApproach Medical Technology Main Business Overview
11.18.5 Shenzhen MicroApproach Medical Technology Latest Developments
11.19 Beijing Demax Medical Technology
11.19.1 Beijing Demax Medical Technology Company Information
11.19.2 Beijing Demax Medical Technology Coronary Pathway Products Product Offered
11.19.3 Beijing Demax Medical Technology Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Beijing Demax Medical Technology Main Business Overview
11.19.5 Beijing Demax Medical Technology Latest Developments
11.20 Xiamen New Concept Medical Technology
11.20.1 Xiamen New Concept Medical Technology Company Information
11.20.2 Xiamen New Concept Medical Technology Coronary Pathway Products Product Offered
11.20.3 Xiamen New Concept Medical Technology Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Xiamen New Concept Medical Technology Main Business Overview
11.20.5 Xiamen New Concept Medical Technology Latest Developments
11.21 Jiangsu ChangMei Medtech
11.21.1 Jiangsu ChangMei Medtech Company Information
11.21.2 Jiangsu ChangMei Medtech Coronary Pathway Products Product Offered
11.21.3 Jiangsu ChangMei Medtech Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Jiangsu ChangMei Medtech Main Business Overview
11.21.5 Jiangsu ChangMei Medtech Latest Developments
11.22 Jiangxi Hongda Medical Equipment Group
11.22.1 Jiangxi Hongda Medical Equipment Group Company Information
11.22.2 Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Product Offered
11.22.3 Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Jiangxi Hongda Medical Equipment Group Main Business Overview
11.22.5 Jiangxi Hongda Medical Equipment Group Latest Developments
11.23 Changzhou JIUHONG Medical Instrument
11.23.1 Changzhou JIUHONG Medical Instrument Company Information
11.23.2 Changzhou JIUHONG Medical Instrument Coronary Pathway Products Product Offered
11.23.3 Changzhou JIUHONG Medical Instrument Coronary Pathway Products Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Changzhou JIUHONG Medical Instrument Main Business Overview
11.23.5 Changzhou JIUHONG Medical Instrument Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
